Health FDA Grants Approval for Sanofi’s Key BTK Inhibitor The U.S. Food and Drug Administration (FDA) has approved a breakthrough Bruton’s tyrosine kinase (BTK) inhibitor, a pivotal component of Sanofi’s immunology strategy. This... Editorial23 hours ago